Position in EXEL
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$18,336
+$4,054 QoQ
Shares Held
337
+1.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#649
of 751 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 20261015 Capital Partners, LLC holds $35,719 across 10 Biotechnology names. EXEL ranks #1 (51.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
This page
|
337 | $18,336 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17 | $10,600 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7 | $3,477 | |
| 4 | INCY |
Incyte Corp
|
9 | $1,020 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3 | $903 | |
| 6 | MRNA |
Moderna, Inc.
|
6 | $420 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2 | $374 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
9 | $318 |
All Filings in EXEL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,336 | 337 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $14,282 | 333 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $15,033 | 343 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||